These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor. Das A, Frank RN, Zhang NL, Samadani E. Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050 [Abstract] [Full Text] [Related]
3. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Robison WG, Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D. Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393 [Abstract] [Full Text] [Related]
4. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane. Nagata M, Robison WG. Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719 [Abstract] [Full Text] [Related]
6. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat. Das A, Frank RN, Zhang NL. Diabetologia; 1990 Sep; 33(9):515-21. PubMed ID: 2123806 [Abstract] [Full Text] [Related]
9. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil. Frank RN, Keirn RJ, Kennedy A, Frank KW. Invest Ophthalmol Vis Sci; 1983 Nov 16; 24(11):1519-24. PubMed ID: 6642931 [Abstract] [Full Text] [Related]
10. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition. Engerman RL, Kern TS, Garment MB. J Diabetes Complications; 1993 Nov 16; 7(4):241-5. PubMed ID: 8219367 [Abstract] [Full Text] [Related]
11. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors. Lightman S, Rechthand E, Terubayashi H, Palestine A, Rapoport S, Kador P. Diabetes; 1987 Nov 16; 36(11):1271-5. PubMed ID: 3117606 [Abstract] [Full Text] [Related]
13. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Robison WG, Nagata M, Tillis TN, Laver N, Kinoshita JH. Invest Ophthalmol Vis Sci; 1989 Nov 16; 30(11):2293-9. PubMed ID: 2509396 [Abstract] [Full Text] [Related]
14. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats. Chakrabarti S, Sima AA. Diabetes; 1989 Sep 16; 38(9):1181-6. PubMed ID: 2504638 [Abstract] [Full Text] [Related]
15. NIH conference. Aldose reductase and complications of diabetes. Cogan DG, Kinoshita JH, Kador PF, Robison G, Datilis MB, Cobo LM, Kupfer C. Ann Intern Med; 1984 Jul 16; 101(1):82-91. PubMed ID: 6203454 [Abstract] [Full Text] [Related]
16. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Arch Ophthalmol; 1990 Sep 16; 108(9):1301-9. PubMed ID: 2119169 [Abstract] [Full Text] [Related]
17. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tsai JY, Kador PF. Invest Ophthalmol Vis Sci; 1999 Mar 16; 40(3):697-704. PubMed ID: 10067973 [Abstract] [Full Text] [Related]
18. Prevention or moderation of some ultrastructural changes in the RPE and retina of galactosemic rats by aldose reductase inhibition. Vinores SA, Campochiaro PA. Exp Eye Res; 1989 Sep 16; 49(3):495-510. PubMed ID: 2507341 [Abstract] [Full Text] [Related]
19. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Engerman RL, Kern TS. Diabetes; 1993 Jun 16; 42(6):820-5. PubMed ID: 8495805 [Abstract] [Full Text] [Related]
20. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats. Robison WG, Jacot JL, Glover JP, Basso MD, Hohman TC. Invest Ophthalmol Vis Sci; 1998 Sep 16; 39(10):1933-41. PubMed ID: 9727416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]